Reed Geoffrey M, First Michael B, Kogan Cary S, Hyman Steven E, Gureje Oye, Gaebel Wolfgang, Maj Mario, Stein Dan J, Maercker Andreas, Tyrer Peter, Claudino Angelica, Garralda Elena, Salvador-Carulla Luis, Ray Rajat, Saunders John B, Dua Tarun, Poznyak Vladimir, Medina-Mora María Elena, Pike Kathleen M, Ayuso-Mateos José L, Kanba Shigenobu, Keeley Jared W, Khoury Brigitte, Krasnov Valery N, Kulygina Maya, Lovell Anne M, de Jesus Mari Jair, Maruta Toshimasa, Matsumoto Chihiro, Rebello Tahilia J, Roberts Michael C, Robles Rebeca, Sharan Pratap, Zhao Min, Jablensky Assen, Udomratn Pichet, Rahimi-Movaghar Afarin, Rydelius Per-Anders, Bährer-Kohler Sabine, Watts Ann D, Saxena Shekhar
Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.
World Psychiatry. 2019 Feb;18(1):3-19. doi: 10.1002/wps.20611.
Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11's approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.
2019年5月世界卫生大会批准《国际疾病分类第11版》(ICD - 11)后,世界卫生组织(WHO)成员国将从ICD - 10过渡到ICD - 11,基于新系统的健康统计报告将于2022年1月1日开始。WHO精神卫生和物质滥用司将在ICD - 11获得批准后发布ICD - 11精神、行为和神经发育障碍的临床描述和诊断指南(CDDG)。在过去十年中,基于临床实用性和全球适用性原则制定的ICD - 11 CDDG,是精神障碍分类有史以来最具广泛国际性、多语言、多学科和参与性的修订过程。ICD - 11的创新之处包括提供一致且系统表征的信息、采用全生命周期方法以及针对每种障碍提供与文化相关的指导。维度方法已被纳入分类中,特别是针对人格障碍和原发性精神障碍,其方式与当前证据一致,更符合基于康复的方法,消除了人为的共病现象,并能更有效地捕捉随时间的变化。在此,我们描述了与ICD - 10相比,ICD - 11精神障碍分类结构的主要变化,以及与精神卫生实践相关的两个新的ICD - 11章节的制定情况。我们举例说明了已添加到ICD - 11中的一组新类别,并阐述了将其纳入的理由。最后,我们描述了在每个ICD - 11障碍分组中所做的重要更改。这些信息旨在帮助临床医生和研究人员熟悉ICD - 11,并为在其各自专业环境中实施做好准备。